Regenerative Medicine Entering a New Era
Luoran Shang,Yuanjin Zhao,Wenguo Cui
DOI: https://doi.org/10.1002/smll.202204625
IF: 13.3
2022-01-01
Small
Abstract:The development of biomedicine is always coupled with advances in technologies and materials. Regenerative medicine, which aims to repair injured or diseased tissues/organs, has become a multidisciplinary field covering both the basic and engineering fields of life sciences. The general strategy in regenerative medicine is the use of cells, together with materials, to eventually promote tissue healing or create replacement tissues. During this process, biomaterials serve as scaffolds and provide mechanical and biochemical cues to modulate cell behaviors. A representative example showing the significant roles of biomaterials is cell culture. Cells and tissues grown in three-dimensional (3D) frameworks more closely resemble the microenvironment in vivo than in traditional two-dimensional (2D) culture. In this respect, the properties of materials, including their chemical composition, micro/nano structure, mechanical feature, biocompatibility, and degradability, etc., are key parameters for the success of tissue engineering and regenerative medicine. In addition, the construction techniques also come into play, considering the requirement for patterning various cells and materials into specific geometries so as to better recapitulate features and functions of native tissues. Overall, the progress in regenerative medicine, throughout its development history, is greatly dependent on the joint efforts in life science, medicine, material science and engineering technologies. In the past few decades, a large number of new materials and technologies have emerged, propelling the field of regenerative medicine into a new era (Figure 1). On one hand, biomaterials are transcending from simple conformations into “smart” ones that can respond to the surrounding environmental stimuli, such as temperature, light, humidity, pH, and stress. These smart biomaterials lay the foundation for understanding complex cell–material interactions and provide rich methods for controlling cellular behaviors. On the other hand, biotechnologies and material processing technologies, including but not restricted to synthetic biology, micro/nano fabrication, electrospinning, 3D/4D printing, microfluidics, organ-on-a-chip, etc., have spurred the advance of tissue engineering. These techniques enable the design and rebuilding of tissue constructs with high resolution and better biomimicry of native tissues and organs. In this Special Issue of Small, we have assembled a collection of research works as well as viewpoints focusing on new technologies and biomaterials for regenerative medicine. This Special Issue has 21 original Research Articles and 9 Reviews that cover the latest progress in this field. Stimuli-responsive materials and smart sensors, actuators, and robotics, are favorable in biomedical fields. Pumera's group presents a light-driven microrobots for biofilm eradication (smll.202106612). Yu's group introduces “drawn-on-skin” sensors for electrophysiological health monitoring (smll.202107099). Shang's group summarizes the recent progress of smart film actuators in biomedical applications (smll.202105116). Zheng's group presents pH-responsive coatings for enhancing osteogenic differentiation (smll.202106056). Santos's group overviews stimuli-responsive biomaterials for the treatment of cardiovascular and cerebrovascular diseases (smll.202200291). Hydrogels and composite hydrogel materials possess unique advantages for regenerative medicine applications. Zhang's group demonstrates that a natural hydrogel showing pro-healing properties could enhance tendon regeneration (smll.202105255). Yu's group develops a hybrid hydrogel system for bone regeneration (smll.202107991). Burdick's group creates injectable granular hydrogels allowing for cell invasion (smll.202201115). Fan's group reviews programmable DNA hydrogels and their role as artificial extracellular matrix (smll.202107640). Other functional materials, including functional extracellular vesicles (Kim's group, smll.202106569) and triboelectric nanogenerators (Cha's group, smll.202107316) are also included in this collection. Besides, materials’ mechanical features and degradation properties are vital for their functions, which are discussed by Yang's group and García's group (smll.202203003 and smll.202106896). Guo's group digs into mechanobiology of cells and analyzes the relevance for translational medicine (smll.202107305). Advanced delivery systems play a significant role in disease treatment and regenerative medicine. Zhang's group develops novel carrier-free nano-theranostic agents toward tumor therapy (smll.202106000). Zhang's group introduces photothermal vehicles for on-site inflammation reduction (smll.202106746). Bian's group reveals the effect of nanoparticles’ shape on T cell activation and immunotherapy outcomes (smll.202107373). Zhao's group summarizes the synthesis of nanoparticles through microfluidics for drug delivery (smll.202106580). Apart from nanoparticles, microparticles have also been widely used for drug delivery and immune modulation. This includes the injectable and adhesive hydrogel microspheres, presented by Cui's group, for inner ear treatment (smll.202106591), as well as the biosignal-functional microspheres for bone defect regeneration (smll.202201656). Besides, gene and cell delivery platforms have been realized with the use of various carriers such as micro-fragmented nanofiber-hydrogel (Mao's group, smll.202202309), combination of nanoneedles and nanofilms (Stevens's group, smll.202202303), and microparticles (Ren's group, smll.202200858). In view of the advanced technologies, electrospray and electrospinning are powerful tools for the synthesis of microspheres (Zhao's group, smll.202200314) and fiber scaffolds (Qian's group, smll.202200799). 3D/4D printing brings revolutions to the development of materials and devices with customized configurations and tailorable properties. This technique has been implemented in the fabrication of microgel scaffolds for cell culture (Anseth's group, smll.202200951) and cell condensate-laden bilayers and constructs (Alsberg's group, smll.202202196). For more comprehensive information about 3D/4D printing for regenerative medicine, readers are suggested to refer to critical reviews presented by Yuan's group (smll.202106824) and Gu's group (smll.202201869). In addition to techniques used for material fabrication, advanced therapeutic methods and platforms, such as thermal therapy, has emerged together with the development of nanotechnology. Tao's group gives an excellent overview of this field (smll.202107705). Although this Special Issue does not cover every aspect of this field, we hope that our collection will help to identify the general principles, current status, and future trends of regenerative medicine. We believe that regenerative medicine will continue to flourish, not only gaining inspirations from new materials and technologies, but also pushing them forward, promoting the integration of multidisciplinary research. Ultimately, we envision that regenerative medicine could take a leap from bench to bedside, and bring revolutions to human healthcare. Luoran Shang is currently an assistant professor at Institutes of Biomedical Sciences, Fudan University. She received her Ph.D. degree from Southeast University in 2017 under the supervision of Prof. Yuanjin Zhao. She worked as a postdoctoral fellow at Harvard University with Prof. David Weitz from 2017 to 2019. Her current scientific interests focus on microfluidics and their biomedical applications. Yuanjin Zhao is a full professor at Nanjing Drum Tower Hospital and Southeast Univerisity. He received his Ph.D. degree in 2011 from Southeast University. From 2009 to 2010, he worked as a research scholar at Prof. David A. Weitz's group in Harvard University. He is Fellow of the Royal Society of Chemistry (FRSC). His current scientific interests include microfluidics, organs-on-chips, biosensors, and advanced bioengineering techniques. Wenguo Cui is a full professor at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. He received his Ph.D. degree in 2009 from Southwest Jiaotong University. From 2013 to 2014, he worked as a research scholar at Prof. David A. Weitz's group in Harvard University. Currently, he is Fellow of the Royal Society of Chemistry (FRSC) and Fellow of Chinese Society of Biomaterials (FCSB). His scientific interests focus on regenerative biomaterials using electrospinning and microfluidics.